Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Michael Holers

Showing results (1-10 of 343) with videos related to

Pageof 35
Sort By:
Clinical Immunology (Orlando, Fla.)|June 14, 2003
The complement system as a therapeutic target in autoimmunityV Michael Holers
Immunological Reviews|July 11, 2008
The spectrum of complement alternative pathway-mediated diseasesV Michael Holers
Immunobiology|May 23, 2025
Systemic lupus erythematosus as the paradigm for understanding the complex immune relationships and therapeutic opportunities for targeting complement in autoimmune diseasesV Michael Holers
The Journal of Clinical Investigation|June 4, 2013
Human C3 glomerulopathy provides unique insights into complement factor H-related protein functionV Michael Holers
Seminars in Arthritis and Rheumatism|November 29, 2023
Are there causal mucosal drivers in the preclinical development of rheumatoid arthritis?V Michael Holers
The Journal of Clinical Investigation|September 3, 2004
Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosusV Michael Holers
Springer Seminars in Immunopathology|December 23, 2004
Complement receptors and the shaping of the natural antibody repertoireV Michael Holers
Arthritis & Rheumatology (Hoboken, N.J.)|August 11, 2020
Challenges and Opportunities: Using Omics to Generate Testable Insights Into Pathogenic Mechanisms in Preclinical Seropositive Rheumatoid ArthritisV Michael Holers
Nature Reviews. Rheumatology|June 19, 2023
Complement therapeutics are coming of age in rheumatologyV Michael Holers
Annals of the Rheumatic Diseases|April 19, 2026
The evolving landscape of complement therapeutics in rheumatologyV Michael Holers
Pageof 35

Showing results (1-10 of 343) with videos related to

Sort By:
Pageof 35
Clinical Immunology (Orlando, Fla.)|June 14, 2003
The complement system as a therapeutic target in autoimmunityV Michael Holers
Immunological Reviews|July 11, 2008
The spectrum of complement alternative pathway-mediated diseasesV Michael Holers
Immunobiology|May 23, 2025
Systemic lupus erythematosus as the paradigm for understanding the complex immune relationships and therapeutic opportunities for targeting complement in autoimmune diseasesV Michael Holers
The Journal of Clinical Investigation|June 4, 2013
Human C3 glomerulopathy provides unique insights into complement factor H-related protein functionV Michael Holers
Seminars in Arthritis and Rheumatism|November 29, 2023
Are there causal mucosal drivers in the preclinical development of rheumatoid arthritis?V Michael Holers
The Journal of Clinical Investigation|September 3, 2004
Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosusV Michael Holers
Springer Seminars in Immunopathology|December 23, 2004
Complement receptors and the shaping of the natural antibody repertoireV Michael Holers
Arthritis & Rheumatology (Hoboken, N.J.)|August 11, 2020
Challenges and Opportunities: Using Omics to Generate Testable Insights Into Pathogenic Mechanisms in Preclinical Seropositive Rheumatoid ArthritisV Michael Holers
Nature Reviews. Rheumatology|June 19, 2023
Complement therapeutics are coming of age in rheumatologyV Michael Holers
Annals of the Rheumatic Diseases|April 19, 2026
The evolving landscape of complement therapeutics in rheumatologyV Michael Holers
Pageof 35